Not all AI partners in pharmacovigilance (PV) are equally prepared to deliver enterprise-scale results. As organizations look to accelerate AI adoption, many face unnecessary risk by relying on vendors lacking proven experience in operationalizing AI across complex global PV environments.

When patient safety, regulatory compliance, operational performance and your reputation are on the line, you need a trusted partner with proven technology, deep PV expertise, and a demonstrated track record of delivering measurable AI-fueled outcomes. Not just for today, but also tomorrow.

Our recent checklist outlines what you should look for in an AI partner in PV to ensure you get the most out of your investment – and in this blog, we outline 5 of those top factors.

The Hidden Risks of Choosing the Wrong AI Vendor in PV

As AI becomes increasingly central to PV workflows and operational efficiency, the greatest competitive advantage won’t simply come from adopting AI. Rather, it will come from partnering with an organization that has already proven it can successfully operationalize AI at enterprise scale.

Organizations that fail to work with this kind of vendor often struggle with:

• Roadmap promises that fail to be delivered down the line

• Operational disadvantages leading to disappointing ROI

• Complex, time-consuming deployments and delayed value realization

• Increased risk and failed pilots

• Difficulty in futureproofing and scaling to meet global PV operations

As AI innovation accelerates, the cost of choosing the wrong partner extends far beyond implementation challenges, impacting long-term competitiveness, agility, and business value.

5 Essential Attributes of a Proven AI PV Partner

Success in AI adoption depends on more than selecting the right technology. It requires choosing a partner with the experience, investment, and proven ability to translate AI innovation into real-world outcomes. Choosing the right partner matters more than ever, to help you deliver proven results today, while eliminating the risk of waiting for promises to become reality.

When evaluating AI partners in PV, below are some of the most critical elements to prioritize:

• Proven AI Operationalization – Invest in a proven provider that is already delivering measurable outcomes across the PV lifecycle, moving beyond case intake throughout the PV lifecycle.

• Sustained R&D AI Investment – Work with a partner committed to continuous capital investment in AI-forward innovation to future-proof your PV operations and ensure you are always leveraging the latest technologies.

• Promises Made, Promises Kept – Avoid empty roadmap promises by using a provider with a track record of delivering compliant AI software as promised and according to established timelines.

• Rapid Time-to-Value – See value faster while preserving existing technology investments by choosing AI that can be deployed quickly and easily, either modularly or across the end-to-end PV ecosystem.

• Enterprise-Scale Expertise – Prioritize an AI provider with a platform purpose-built to support global PV operations, with extensive industry expertise and successful enterprise-scale deployments.

By focusing on these key attributes, life sciences organizations can bridge the gap from promises to real-world results, reduce risk, accelerate value realization, and build a foundation for sustainable AI success across the PV lifecycle.

Experience Proven AI in PV – Backed by the Trusted Leader

At ArisGlobal, we don’t just envision the future of AI in pharmacovigilance. We build it, validate it, and deliver it into production, with customers already realizing proven AI operationalization in PV.

Through AI-forward innovation, powered by NavaX, we ensure access to the latest advancements in GenAI, Agentic AI, intelligent automation, and cognitive computing as they become available.

Our solutions are helping global life sciences organizations accelerate case intake, field reporting, signal and risk management and more, all while demonstrating real returns throughout the safety lifecycle.

Backed by sustained investment in research and development, continuous product innovation, and decades of pharmacovigilance expertise, ArisGlobal delivers on its promises and gives organizations confidence that today’s AI investments will continue to evolve alongside tomorrow’s business needs.

Proven Results: The Measurable, Real-World Impact

When evaluating AI partners, evidence matters. Move beyond AI experimentation with production-scale capabilities already delivering measurable outcomes across real-world PV environments.

See why top industry leaders trust ArisGlobal as their AI partner and how customers are transforming pharmacovigilance operations today.

This includes:

• Accelerating case intake with efficiency gains of 30%.

• Maintaining 95% accuracy with dynamic data extraction.

• Achieving a 90% narrative similarity score with AI narrative generation.

• Driving up to 70% faster literature reference processing.

• Enabling up to 65% faster front-end patient data collection

• Turn hours of work to minutes via rapid, intelligence-driven signal management.

• Realizing up to a 40% reduction in vendor personnel spend.

The difference between AI ambition and AI success is execution, and these results show how ArisGlobal delivers both measurable ROI and sustainable competitive advantage.

Take the Next Step Toward AI-Forward PV

The question is no longer whether AI will transform PV – it’s how quickly organizations can harness its value at scale.

Ready to learn more? Check out our checklist for a deeper look at what criteria to keep in mind when evaluating AI providers in PV, to get the most out of your investment.